Results 181 to 190 of about 15,266 (342)

Hot Spots in Urogenital Basic Cancer Research and Clinics. [PDF]

Cancers (Basel)
Manini C, Larrinaga G, Angulo JC, López JI.   +3 more
europepmc   +1 more source

IL-10 Polymorphisms and Urologic Neoplasms Risk: A Meta-Analysis

Medical Science Review, 2015
Xianguo Chen, Kaiping Zhang, Cheng Yang, Chaozhao Liang, Li Zhang   +4 more
openaire   +2 more sources

Sentinel lymph node staging in urological cancer surgery: advances in imaging, intra‐operative detection and translational research

BJU International, EarlyView.
Objectives To review the clinical utility, outcome and possible future applications of sentinel lymph node biopsy (SLNB) in penile cancer (PeC), bladder cancer (BCa), prostate cancer (PCa), testicular cancer (TCa) and renal cell carcinoma (RCC), focusing in particular on current SLNB standards and exploring advancements in imaging agents, intra ...
Erik J. van Gennep, Gijs H. KleinJan, Teele Kuusk, Rick W.A. Verdijk, Esther M.K. Wit, Bas W.G. van Rhijn, Axel Bex, Laura S. Mertens   +7 more
wiley   +1 more source

Serum Matrix Metalloproteinases and Risk of Urologic Cancers: A Bidirectional Mendelian Randomization Study. [PDF]

Am J Mens Health
Yang B, Zeng X, Wang H, Feng J, Hou S.
europepmc   +1 more source

Impact of timing of computed tomography staging and patient factors on the detection of ‘true’ cN+ bladder cancer

BJU International, EarlyView.
Objectives To evaluate whether computed tomography (CT) scans should be performed before or after transurethral resection of bladder tumour (TURBT) for accurate lymph node staging in clinically lymph node‐positive bladder cancer (BCa). Additionally, to identify patient factors that can aid in predicting lymph node metastasis.
Markus von Deimling, Marc Furrer, Alberto Bianchi, Renate Pichler, Moritz Maas, Karl H. Tully, Mattia Longoni, Laura S. Mertens, Jacob Taylor, Francesco del Giudice, Roger Li, Andrea Gallioli, Simone Albisinni, Felice Crocetto, Maud Velev, Luca Afferi, Andrea Mari, Ekaterina Laukhtina, Jakob Klemm, Nirmish Singla, Margit Fisch, Philippe E. Spiess, Yair Lotan, Marco Moschini, Peter C. Black, Alessandro Antonelli, Bernhard Kiss, Shahrokh F. Shariat, Benjamin Pradere, CLIPOLY study group collaborators, Luca Antonelli, Mara Bacchiani, Ronan Flippot, Abhinav Khanna, Elisabeth Maier, Gautier Marcq, Andrea Minvervini, Keiichiro Mori, Maximilian Pallauf, Nicolas Penel, Julien Sarkis, Francesco Soria, Guus A.H. Tendijck, Noor van Ginkel, Solomon Woldu   +44 more
wiley   +1 more source

Changes in urologic research from a new perspective: Text mining analysis of publication topics. [PDF]

Investig Clin Urol
Joo S, Lu K, Park J, Rho MJ, Park YH.
europepmc   +1 more source

Extraperitoneal single‐site robot‐assisted radical prostatectomy with extended pelvic lymph node dissection: technique and experience

BJU International, Volume 135, Issue 4, Page 700-705, April 2025.
Yubo Wang, Mingzhao Li, Kai Yao, Zhuyinjun Zong, Yifan Chang, Yongda Liu, Chao Cai, Fadi Mousa Al Kalailah, Shancheng Ren, Guohua Zeng, Di Gu   +10 more
wiley   +1 more source

Transcriptome profiling of prostatic tumours from ENACT trial patients with or without enzalutamide

BJU International, EarlyView.
Objectives To evaluate the longitudinal transcriptomic changes that occurred over time in patients from the ENACT trial (ClinicalTrials.gov identifier: NCT02799745). ENACT evaluated patients with low‐ or intermediate‐risk prostate cancer, comparing the efficacy and safety of enzalutamide plus active surveillance (AS) to AS alone.
Nicole Handa, Neal D. Shore, Matthew R. Cooperberg, Elai Davicioni, Xin Zhao, Dina Elsouda, Yang Liu, James A. Proudfoot, Gaston Kuperman, David Russell, Kenneth K. Iwata, Edward M. Schaeffer, Ashley Ross   +12 more
wiley   +1 more source

Metastatic seminoma from an undescended intra-abdominal testis: Case report and review of management. [PDF]

Urol Case Rep
Tariqi R, Ibrahimi A, El Abidi H, Abaair Y, Bouaoudate M, Darquaoui S, Boualaoui I, El Sayegh H, Nouini Y.   +8 more
europepmc   +1 more source

Guideline of guidelines: PSMA PET in staging newly diagnosed intermediate‐risk prostate cancer

BJU International, EarlyView.
Objective To provide a comprehensive review and analysis of guidelines from various professional and medical organisations regarding the use of prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) as a staging scan for men with newly diagnosed intermediate‐risk prostate cancer (PCa).
Jonathon Carll, Weiwei Shi, Marlon Perera, Nathan Lawrentschuk, Thilakavathi Chengodu, Dixon Woon   +5 more
wiley   +1 more source